Quantbot Technologies’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3,300
| Closed | -$435K | – | 1931 |
|
|
2025
Q3 | $435K | Buy |
+3,300
| New | +$396K | 0.01% | 1078 |
|
|
2024
Q1 | – | Sell |
-7,263
| Closed | -$893K | – | 1742 |
|
|
2023
Q4 | $893K | Buy |
+7,263
| New | +$906K | 0.05% | 531 |
|
|
2023
Q1 | – | Sell |
-9,153
| Closed | -$1.46M | – | 1796 |
|
|
2022
Q4 | $1.46M | Buy |
+9,153
| New | +$1.34M | 0.1% | 291 |
|
|
2021
Q4 | – | Sell |
-12,875
| Closed | -$1.68M | – | 1701 |
|
|
2021
Q3 | $1.68M | Buy |
+12,875
| New | +$1.95M | 0.12% | 229 |
|
|
2021
Q2 | – | Sell |
-2,150
| Closed | -$353K | – | 1654 |
|
|
2021
Q1 | $353K | Buy |
+2,150
| New | +$354K | 0.03% | 581 |
|
|
2020
Q2 | – | Sell |
-138
| Closed | -$13K | – | 1273 |
|
|
2020
Q1 | $13K | Sell |
138
-6,110
| -98% | -$790K | 0.01% | 657 |
|
|
2019
Q4 | $932K | Buy |
6,248
+4,446
| +247% | +$605K | 0.09% | 263 |
|
|
2019
Q3 | $230K | Buy |
+1,802
| New | +$242K | 0.02% | 666 |
|
|
2019
Q2 | – | Sell |
-4,060
| Closed | -$580K | – | 1310 |
|
|
2019
Q1 | $580K | Sell |
4,060
-4,997
| -55% | -$652K | 0.06% | 397 |
|
|
2018
Q4 | $1.12M | Buy |
9,057
+5,049
| +126% | +$749K | 0.11% | 260 |
|
|
2018
Q3 | $673K | Sell |
4,008
-1,213
| -23% | -$209K | 0.05% | 481 |
|
|
2018
Q2 | $899K | Buy |
+5,221
| New | +$853K | 0.06% | 421 |
|
|
2018
Q1 | – | Sell |
-4,131
| Closed | -$556K | – | 1357 |
|
|
2017
Q4 | $556K | Buy |
+4,131
| New | +$573K | 0.05% | 476 |
|
|
2017
Q2 | – | Sell |
-6,273
| Closed | -$910K | – | 1230 |
|
|
2017
Q1 | $910K | Buy |
6,273
+1
| +0% | +$130 | 0.1% | 257 |
|
|
2016
Q4 | $683K | Sell |
6,272
-7,700
| -55% | -$858K | 0.08% | 271 |
|
|
2016
Q3 | $1.7M | Sell |
13,972
-5,852
| -30% | -$789K | 0.19% | 142 |
|
|
2016
Q2 | $2.8M | Buy |
+19,824
| New | +$2.92M | 0.3% | 96 |
|
|
2016
Q1 | – | Sell |
-6,974
| Closed | -$980K | – | 1271 |
|
|
2015
Q4 | $980K | Buy |
+6,974
| New | +$966K | 0.17% | 156 |
|
|
2015
Q1 | – | Sell |
-2,742
| Closed | -$448K | – | 1196 |
|
|
2014
Q4 | $448K | Buy |
+2,742
| New | +$455K | 0.14% | 215 |
|
|
2014
Q1 | – | Sell |
-200
| Closed | -$25K | – | 1217 |
|
|
2013
Q4 | $25K | Buy |
+200
| New | +$20.7K | 0.01% | 759 |
|
Other funds holding JAZZ
EC
Quantbot Technologies's JAZZ Position: Q4 2025 in Review
Quantbot Technologies sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2025, closing a stake of 3,300 shares — an estimated $435K sold.
Quantbot Technologies first reported a position in JAZZ in Q4 2013 and held it in 20 quarters. The position peaked at $2.8M in Q2 2016. 573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.
- Quantbot Technologies reported no remaining Jazz Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Quantbot Technologies sold 3,300 Jazz Pharmaceuticals shares in Q4 2025, an estimated $435K.
- Quantbot Technologies first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 20 quarters.
- Quantbot Technologies's Jazz Pharmaceuticals position peaked at $2.8M in Q2 2016.
- 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.
Based on Quantbot Technologies's 13F filing for Q4 2025, filed 10 Feb 2026.